Locate Technologies to convert PURE royalty into equity
NZX MARKET ANNOUNCEMENT | 30 June 2026
Locate Technologies to convert PURE royalty into equity
Locate Technologies Limited (NZX: LOC) (Locate Technologies or the Company) today
announced that it has agreed with PURE Asset Management Pty Ltd as trustee for The
Income and Growth Fund (PURE), the Company's debt funder, to buy out the remaining
Locate2u revenue royalty and settle it through the issue of ordinary shares in the Company.
Under existing arrangements, the Company paid PURE a royalty of 2.5% of Locate2u
monthly revenue. Originally capped at A$0.75m, through quarterly payments this has been
reduced to A$0.56m.
The Company will issue 10,000,000 new ordinary shares to PURE in full settlement of the
royalty. That equates to an implied issue price of about 6.8 cents per share, a significant
premium to the recent market price of 4.7 cents. The obligation is in Australian dollars and is
translated to New Zealand dollars at the rate fixed in the conversion deed.
The issue is within the Company's 15% annual placement capacity under the NZX Listing
Rules and does not require shareholder approval. PURE is not a related party of the
Company. Following the issue, PURE will become a substantial product holder and will file
the required disclosure.
Commentary
Commenting on the transaction, Locate Technologies Chief Executive Officer Steve
Orenstein said: “Converting the remaining royalty into equity removes a claim on Locate2u's
revenue as the platform grows, simplifies our funding arrangements, improves cashflow and
further aligns PURE with our shareholders. It is an excellent outcome for both parties and
illustrates the faith PURE has in the future of the Company.
Authorisation
This announcement was authorised for release by the Board of Locate Technologies Limited.
For further information:
Steve Orenstein
CEO
Locate Technologies Limited
investors@locatetech.nz
Locate Technologies Limited (NZX: LOC) Page 1
About Locate Technologies
Locate Technologies Limited (NZX: LOC) is an AI-powered delivery and logistics technology
company. The Group operates two complementary platforms: Locate2u, a route optimisation
and delivery management platform used by fleet operators, retailers, and logistics providers
internationally, with AI features deployed in the product for customers; and Zoom2u, an
on-demand courier and delivery marketplace across Australia that uses AI internally to run
its dispatch and logistics operations. The Group's platforms provide route planning, delivery
management, and real-time visibility for businesses of all sizes.
Locate Technologies is also New Zealand's first listed Bitcoin treasury company, holding
Bitcoin as a reserve asset alongside its operating businesses.
This announcement may contain forward-looking statements. These are based on current expectations and are
subject to risks and uncertainties that could cause actual results to differ. The Company does not undertake to
update any forward-looking statement except as required by law.
Locate Technologies Limited (NZX: LOC) Page 2
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- RUA — Rua Bioscience Limited: Capital Change Notice - Convertible Note2026-08-10
“Products of the Class held as Treasury Stock after the issue/acquisition/redemption. be on issue: 345,441,705 ordinary shares Total warrants on issue would remain at: 8,062,512 warrants In the case of an acquisition of shares, whether those shares are to be held as treasu…”
- RUA — Rua Bioscience Limited: Rua Bioscience approves Convertible Note Facility2026-08-09
“PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com FOR PUBLIC RELEASE NZX Limited Wellington 10 August 2026 Rua Bioscience approves Convertible Note Facility The Board of Rua Bioscience have approved a convertible note facility o…”
- NZL — New Zealand Rural Land Company Limited: Issue of Performance Fee Shares2026-05-20
“20 May 2026 Issue of Performance Fee Shares New Zealand Rural Land Company (NZL.NZX) confirms it has issued 257,415 fully paid ordinary shares to satisfy the Performance Fee for the period ending 31 December 2025 at an issue price of $1.6097 and a further 101,252 fully paid or…”